Grassi Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.8M | Sell |
96,025
-1,225
| -1% | -$228K | 1.42% | 14 |
|
|
2025
Q1 | $20.4M | Sell |
97,250
-675
| -0.7% | -$131K | 1.88% | 11 |
|
|
2024
Q4 | $17.4M | Sell |
97,925
-1,275
| -1% | -$234K | 1.49% | 14 |
|
|
2024
Q3 | $19.6M | Sell |
99,200
-2,300
| -2% | -$429K | 1.69% | 12 |
|
|
2024
Q2 | $17.4M | Sell |
101,500
-750
| -0.7% | -$124K | 1.54% | 13 |
|
|
2024
Q1 | $18.6M | Sell |
102,250
-400
| -0.4% | -$68.9K | 1.68% | 12 |
|
|
2023
Q4 | $15.9M | Hold |
102,650
| – | – | 1.67% | 12 |
|
|
2023
Q3 | $15.3M | Sell |
102,650
-50
| -0% | -$7.34K | 1.76% | 11 |
|
|
2023
Q2 | $13.8M | Sell |
102,700
-100
| -0.1% | -$14.7K | 1.52% | 15 |
|
|
2023
Q1 | $16.4M | Sell |
102,800
-1,175
| -1% | -$180K | 2.03% | 10 |
|
|
2022
Q4 | $16.8M | Hold |
103,975
| – | – | 2.27% | 9 |
|
|
2022
Q3 | $14M | Hold |
103,975
| – | – | 2.03% | 8 |
|
|
2022
Q2 | $15.9M | Sell |
103,975
-1,450
| -1% | -$222K | 2.1% | 8 |
|
|
2022
Q1 | $17.1M | Sell |
105,425
-400
| -0.4% | -$58.1K | 1.79% | 9 |
|
|
2021
Q4 | $14.3M | Sell |
105,825
-400
| -0.4% | -$47.3K | 1.43% | 20 |
|
|
2021
Q3 | $11.5M | Buy |
106,225
+2,225
| +2% | +$254K | 1.29% | 29 |
|
|
2021
Q2 | $11.7M | Sell |
104,000
-225
| -0.2% | -$25.3K | 1.27% | 26 |
|
|
2021
Q1 | $11.3M | Buy |
104,225
+1,475
| +1% | +$158K | 1.28% | 29 |
|
|
2020
Q4 | $11M | Buy |
102,750
+17,910
| +21% | +$1.72M | 1.4% | 27 |
|
|
2020
Q3 | $7.43M | Buy |
84,840
+6,790
| +9% | +$639K | 1.05% | 38 |
|
|
2020
Q2 | $7.66M | Buy |
78,050
+550
| +0.7% | +$48.4K | 1.1% | 40 |
|
|
2020
Q1 | $5.91M | Buy |
77,500
+600
| +0.8% | +$51.1K | 1.03% | 44 |
|
|
2019
Q4 | $6.81M | Hold |
76,900
| – | – | 0.92% | 51 |
|
|
2019
Q3 | $5.82M | Sell |
76,900
-300
| -0.4% | -$20.6K | 0.87% | 51 |
|
|
2019
Q2 | $5.61M | Sell |
77,200
-350
| -0.5% | -$27.5K | 0.83% | 52 |
|
|
2019
Q1 | $6.25M | Sell |
77,550
-55,885
| -42% | -$4.57M | 0.93% | 49 |
|
|
2018
Q4 | $12.3M | Sell |
133,435
-1,357
| -1% | -$119K | 2.11% | 8 |
|
|
2018
Q3 | $12.7M | Sell |
134,792
-348
| -0.3% | -$33K | 1.89% | 10 |
|
|
2018
Q2 | $12.5M | Sell |
135,140
-415
| -0.3% | -$40.5K | 2.01% | 11 |
|
|
2018
Q1 | $12.8M | Sell |
135,555
-1,549
| -1% | -$170K | 2.08% | 12 |
|
|
2017
Q4 | $13.3M | Buy |
137,104
+1,301
| +1% | +$123K | 2.15% | 10 |
|
|
2017
Q3 | $12.1M | Buy |
135,803
+476
| +0.4% | +$36.2K | 2.03% | 9 |
|
|
2017
Q2 | $9.81M | Buy |
135,327
+1,026
| +0.8% | +$69K | 1.73% | 10 |
|
|
2017
Q1 | $8.75M | Sell |
134,301
-199
| -0.1% | -$12.5K | 1.52% | 17 |
|
|
2016
Q4 | $8.42M | Hold |
134,500
| – | – | 1.53% | 18 |
|
|
2016
Q3 | $8.48M | Buy |
134,500
+975
| +0.7% | +$63.1K | 1.59% | 10 |
|
|
2016
Q2 | $8.27M | Sell |
133,525
-1,550
| -1% | -$94.4K | 1.56% | 18 |
|
|
2016
Q1 | $7.71M | Sell |
135,075
-630
| -0.5% | -$35.1K | 1.53% | 17 |
|
|
2015
Q4 | $8.04M | Buy |
135,705
+726
| +0.5% | +$41.8K | 1.64% | 11 |
|
|
2015
Q3 | $7.34M | Sell |
134,979
-948
| -0.7% | -$61.7K | 1.56% | 13 |
|
|
2015
Q2 | $9.13M | Sell |
135,927
-49
| -0% | -$3.2K | 1.72% | 5 |
|
|
2015
Q1 | $7.96M | Buy |
135,976
+1,001
| +0.7% | +$60.5K | 1.48% | 9 |
|
|
2014
Q4 | $8.83M | Buy |
134,975
+8,975
| +7% | +$566K | 1.55% | 6 |
|
|
2014
Q3 | $7.28M | Sell |
126,000
-300
| -0.2% | -$16.7K | 1.38% | 15 |
|
|
2014
Q2 | $7.13M | Sell |
126,300
-400
| -0.3% | -$21K | 1.56% | 12 |
|
|
2014
Q1 | $6.51M | Sell |
126,700
-3,400
| -3% | -$172K | 1.54% | 15 |
|
|
2013
Q4 | $6.87M | Sell |
130,100
-960
| -0.7% | -$47.2K | 1.64% | 13 |
|
|
2013
Q3 | $5.86M | Buy |
131,060
+550
| +0.4% | +$24.4K | 1.55% | 14 |
|
|
2013
Q2 | $5.39M | Buy |
+130,510
| New | +$5.71M | 1.45% | 15 |
|
Other funds holding ABBV
Grassi Investment Management's ABBV Position: Q2 2025 in Review
Grassi Investment Management reduced its AbbVie (ABBV) stake by 1.3% in Q2 2025, selling an estimated $228K and leaving 96,025 shares worth $17.8M. The position accounts for 1.42% of the portfolio, ranked #14.
Grassi Investment Management first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $20.4M in Q1 2025. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.
- Grassi Investment Management held 96,025 shares of AbbVie worth $17.8M as of Q2 2025.
- Grassi Investment Management sold 1,225 AbbVie shares in Q2 2025, an estimated $228K.
- AbbVie made up 1.42% of Grassi Investment Management's portfolio in Q2 2025, its #14 holding.
- Grassi Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
- Grassi Investment Management's AbbVie position peaked at $20.4M in Q1 2025.
- 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.
Based on Grassi Investment Management's 13F filing for Q2 2025, filed 21 Jul 2025.